Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Revimid demonstrates potential in myelodysplastic syndromes

June 5, 2003

Novel VEGFR kinase inhibitors identified by Novartis researchers

June 5, 2003

Potential agent for prostate cancer available for licensing from BTG

June 4, 2003

FeRx opens phase II/III trial of MTC-doxorubicin

June 4, 2003

Mitotic kinesin KSP inhibitors identified at Merck

June 4, 2003

Bayer claims new inhibitors of SPEK kinase and their use in cancer therapy

June 4, 2003

Pharma Mar advances kahalalide F into phase II for liver carcinoma

June 3, 2003

Allos updates operating plan for 2003

June 3, 2003

Amgen and Tularik form oncology collaboration

June 3, 2003

Corixa and GSK enter Bexxar agreement for Canada

June 3, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...